SPI Infoamtion

※このサンプルは会員登録をしなくてもご覧いただけます。

• veterinaryhealth sample  (PDF形式、154 KB)

Table of Contents:

1. Overview
1.1 Objective of Report
1.2 Scope of Report
1.3 Methodology
1.4 Executive Summary

2. Veterinary Biological Products
2.1 Overview of Health Products Market
2.1.1 World Products Markets
2.1.2 U.S. Animal Health Products Market
2.1.3 European Animal Health Markets
2.1.4 Asian Animal Health Products Markets
2.1.5 World Market Share
2.1.6 Common Animal Diseases
2.1.7 Companion Animals
2.2 Veterinary Vaccines
2.2.1 Major Canine Vaccines
2.2.2 Major Feline Vaccines
2.3 Agricultural Animals
2.3.1 Major Cattle Vaccines
2.3.2 Major Poultry Vaccines
2.3.3 Major Sheep Vaccines
2.3.4 Major Swine Vaccines
2.3.5 Major Equine Vaccines
2.4 Trends in the Biologicals Market
2.5 Nutraceuticals
2.5.1 Nutraceutical Market for Companion Animals
2.6 OTC Animal Health Global Market Opportunity

3. Veterinary Pharmaceutical Products
3.1 Overview
3.1.1 Pharmaceutical Products for Dogs and Cats
3.1.1.1 Antiparasitics
3.1.1.2 Antibiotics
3.1.1.3 Anti-Inflammatories
3.1.1.4 Chronic Care Products
3.1.1.5 Cardiovasculars
3.1.1.6 GI Products
3.1.1.7 Endocrine Products
3.1.1.8 Anti-Infectives
3.1.1.9 Behavior Modifiers
3.1.1.10 Anthelminitics
3.1.1.11 Antifungals
3.1.1.12 Cancer and Chemotherapy in Companion Animals
3.1.2 Pharmaceutical Products for Agricultural Animals
3.1.2.1 Antiparasitics
3.1.2.2 Antibiotics
3.1.2.3 Insecticides
3.2 Leading Products and Competitors
3.2.1 Elanco
3.2.2 Novartis
3.2.3 Alpharma
3.2.4 Pfizer Animal Health
3.3 Veterinary Pharmaceutical Market Trends
3.4 Companion-Animal Crossover Products
3.5 Generics in the Animal Health Sector

4. Veterinary Feed Additive Products
4.1 Overview
4.2 U.S. Feed Additives Market
4.3 Leading Feed Additives and Competitors
4.4 Feed Additives Market Trends
4.4.1 Livestock Performance Enhancers
4.5 Pet Food Additives and Contaminants

5. Veterinary Diagnostic Test Products
5.1 Introduction
5.2 Veterinary Diagnostic Market Size and Growth Rates
5.2.1 Market Drivers
5.2.2 Immunodiagnostic and Nucleic Acid Testing Markets
5.2.2.1 Market Size and Growth
5.2.3 Technological Developments in the Diagnostic Industry
5.3 Competitive Situation
5.4 Estimate of Units Sold and Pricing
5.5 PCR Applications for Veterinary Use
5.6 Companion-Animal Diagnostics
5.6.1 Feline Leukemia Virus
5.7 Agricultural Animal Diagnostics
5.8 U.S. Diagnostic Test Market
5.9 Leading Competitors in Diagnostic Testing
5.10 Veterinary Diagnostic Market Trends
5.11 Collaborative Licensing
5.12 BSE Diagnostic Tests
5.13 West Nile Virus Diagnostic Tests
5.14 Avian Flu Diagnostic Tests

6. Overview of the Veterinary Health Market
6.1 Regulatory Environment
6.1.1 International Bodies for Regulation of Animal Health Products
6.1.1.1 Regulation of Animal Health Products in the E.U.
6.1.1.2 Regulation of Animal Health Products in the U.S.
6.1.1.3 Regulation of Animal Health Products in Japan
6.2 The European Animal Health Industry
6.2.1 Trends Driving Demand
6.2.1.1 European, International and U.S. Oversight of Veterinary Medicines
6.2.1.2 Antibiotic Usage
6.3 Mergers and Acquisitions
6.4 New Product Launches
6.5 Bioterrorism and Foodborne Pathogens?WHO Guidelines
6.5.1 The U.S. Bioterrorism Preparedness and Response Act, 2002
6.6 Generic Products

7. Emerging Markets
7.1 Biotechnology and Veterinary Health
7.1.1 Biotechnology and Biologics
7.1.1.1 Recombinant DNA Vaccines
7.1.1.2 Plant-derived Vaccines
7.1.2 DNA Probes
7.1.3 Biotechnology and Pharmaceuticals
7.1.3.1 Immunodiagnostic Applications
7.1.3.2 Growth Enhancers
7.2 Impact of Genomics on Veterinary Health
7.2.1 Autosomal Dominant Traits
7.2.2 X-Linked Traits
7.2.3 Autosomal Recessive Traits
7.2.4 Current DNA Testing in Animals
7.2.5 Direct DNA Testing: Mutation-based Tests
7.2.6 Indirect DNA Testing: Linkage-based or Marker-Based Tests
7.3 Companion-Animal Markets
7.4 Alternative Medicine in Veterinary Practice
7.5 Generics in the Animal Health Market
7.6 Pet Insurance
7.7 Orthotics and Prosthetics for Animals
7.8 Pet Cloning

8. Company Profiles
8.1 Abaxis, Inc.
8.2 Abbott Laboratories
8.3 Adiagene
8.4 Agricultural Research Service
8.5 Alpharma, Inc.
8.6 Avian Biotech
8.7 BASF
8.8 Bayer Animal Health
8.9 Biobest Laboratories
8.10 Biocurex
8.11 BioVet, Inc.
8.12 Boehringer Ingelheim Corp.
8.13 CEVA Sant? Animale
8.14 CJ Corporation
8.15 Cypress Diagnostics
8.16 Dabaco Viet Nam Corporation
8.17 DayMoon Industries, Inc.
8.18 Dow AgroSciences LLC
8.19 Dupont Qualicon
8.21 Egyptian International Pharmaceutical Industries Company
8.22 Elanco Animal Health
8.23 Eurofins Medigenomix GmbH
8.24 Eurovet
8.25 Gene Check, Inc.
8.26 Heska
8.27 Huvepharma
8.28 IDEXX Laboratories, Inc.
8.29 IWAKI & Co., Ltd.
8.30 Janssen Pharmaceutica
8.31 Laboklin
8.32 Medika d.d.
8.33 Merck
8.34 Merial
8.35 MetaMorphix, Inc.
8.36 Microbix Biosystems, Inc.
8.37 Momina krepost AD Veliko Tarnovo
8.38 Mosaic Company
8.39 Neogen Corporation
8.40 Norbrook Laboratories Ltd.
8.41 Novartis Animal Health
8.42 OptiGen
8.43 Orion Corporation
8.44 PETCO Animal Supplies, Inc.
8.45 PetSmart, Inc.
8.46 Pfizer Animal Health
8.47 Phibro Animal Health Corporation
8.48 Phylaxia 1912 Holding NyRt
8.49 Prionics
8.50 Randox
8.51 Sanofi-Aventis
8.52 Skystar Bio-Pharmaceutical Company
8.53 Sunwin International Nutraceuticals
8.54 Synbiotics Corporation
8.55 Teva Pharmaceutical Industries Ltd.
8.56 The Arab Pesticides and Veterinary Drugs Mfg. Co.
8.57 ThermoGenesis Corp.
8.58 VCA Antech, Inc.
8.59 Velefarm ad Beograd
8.60 Veterinarski Zavod Subotica ad Subotica
8.61 V?toquinol
8.62 Virbac SA
8.63 WooGene B&G Co., Ltd

9. Business Trends in the Industry
9.1 Animal Health Additive Growth Trends
9.2 Move to Complete Product Portfolio
9.3 Reduced Antibiotic Usage in Animal Feeds
9.4 European Animal Health Industry
9.5 Licensing and Partnership Opportunities in Animal Health R&D

10. Company Directory

Appendix 1: Dosages for Selected Drugs Alphabetical Listing
Appendix 2: Trade Names
Appendix 3: Abbreviations

INDEX OF FIGURES
Figure 2.1: Global Animal Health Market by Product Category, 2008
Figure 2.2: Worldwide Sales of Animal Health Products by Product Class, 2008
Figure 2.3: Worldwide Animal Health Industry Revenues by Species, 2008
Figure 2.4: Worldwide Animal Health Products Market by Region, 2008
Figure 2.5: Market Share for the Top Ten Animal Health Companies, 2008
Figure 2.6: U.S. Companion Animal Healthcare Products Share of Overall Animal Health Product Sales, 2008
Figure 2.7: Pet Population in Japan, 2006 and 2008
Figure 2.8: Swine Population in Japan, 2006-2008
Figure 2.9: Cattle Population in Japan, 2006-2008
Figure 2.10: The Indian Biologicals Industry by Product Category, 2007
Figure 2.11: Global Incidence of Avian H5N1, 2010
Figure 2.12: Global Outbreaks of Equine Viral Arteritis, 2009
Figure 3.1: Animal Health Product Sales in the U.S., 2005-2014
Figure 3.2: The European Parasiticide Market by Product Category, 2008
Figure 3.3: Growth in Global Sales of Antibiotic Products, 2005-2012
Figure 4.1: Global Market for Livestock Performance Enhancers, 2007
Figure 5.1: Growth of the Lateral Flow Diagnostic Tests in the Veterinary Market, 2005-2015
Figure 7.1: The U.S. Market for Animal Pharmaceuticals, 2012
Figure 7.2: U.S. Animal Pharmaceuticals: Percentage of New Generics, 2010
Figure 7.3: U.S. Market for FDA-approved Pharmaceuticals for Companion Animals, 2008

LIST OF TABLES
Table 2.1: World Market for Animal Health Products, 2002-2012
Table 2.2: Global Sales of Animal Health and Nutrition Products, 2004-2012
Table 2.3: Worldwide Animal Health Products Market by Region, 2008
Table 2.4: U.S. Animal Health Product Sales, 2005-2014
Table 2.5: Animal Health Market: Sales Statistics-Europe, 2008
Table 2.6: E.U. Animal Health Market, 2004-2015
Table 2.7: Japanese Animal Health Market, 2000-2012
Table 2.8: Chinese Animal Health and Nutrition Market, 2005-2012
Table 2.9: Indian Animal Health Market, 2003-2012
Table 2.10: Institutions Involved in Manufacturing Vaccines and Other Biological Products for Livestock
Table 2.11: Worldwide Animal Health Product Sales for Leading Producers, 2009
Table 2.12: Common Animal Diseases
Table 2.13: Cattle Diseases
Table 2.14: Sheep and Goat Diseases
Table 2.15: Equine Diseases
Table 2.16: Swine Diseases
Table 2.17: Avian Diseases
Table 2.18: Fish Diseases
Table 2.19: Other Infectious Diseases
Table 2.20: U.S. expenditure on pet products and services, 1994-2010
Table 2.21: Estimated Pet Product Sales, by Category, within the U.S. Market, 2010
Table 2.22: Worldwide Veterinary Vaccine Market, 2005-2012
Table 2.23: U.S. Veterinary Vaccine Market, 2004-2013
Table 2.24: Second-Generation Licensed/Commercialized Veterinary Viral Vaccines
Table 2.25: Canine Vaccinations
Table 2.26: Dog Vaccine Price List
Table 2.27: American Association of Feline Practitioners Feline Vaccination Guidelines
Table 2.28: Recently Commercialized Veterinary Bacterial Vaccines
Table 2.29: Available Veterinary Live Protozoal Vaccines
Table 2.30: Available Veterinary Killed/Subunit Protozoal Vaccines
Table 2.31: Commercialized Reproduction Control Vaccines
Table 2.32: Global Market for Nutraceutical in Companion Animals, 2005-2012
Table 3.1: Veterinary Drugs Listed by Therapeutic Class
Table 3.2: Sales of Pharmaceutical Products for Animal Health in the U.S., 2002-2012
Table 3.3: Number of Dogs in the U.S., 1996-2009
Table 3.4: Number of Cats in the U.S., 1996-2009
Table 3.5: Number of Companion Animals by Country, 2009
Table 3.6: American Veterinary Specialists
Table 3.7: Companion-Animal Products Sales, 2009
Table 3.8: U.S. Antiparistic Animal Health Product Sales, 2005-2012
Table 3.9: Global Antiparistic Animal Health Product Sales, 2005-2012
Table 3.10: Worldwide Sales of Animal Health Antibiotics, 2005-2014
Table 3.11: U.S. Sales of Animal Health Antibiotics, 2005-2014
Table 3.12: European Sales of Animal Health Antibiotics, 2005-2012
Table 3.13: Common Veterinary Anti-Inflammatories
Table 3.14: U.S. Pet Anti-Inflammatory Market, 2003-2012
Table 3.15: Retail Pricing of Rimadyl
Table 3.16: EtoGesic Pricing
Table 3.17: Therapy for Various Pet Cancers
Table 3.18: Mechanisms of Action, Indications and Toxicities of Selected Antineoplastic Agents
Table 3.19: Treatment Options for Canine or Feline Lymphomas
Table 3.20: Chemotherapeutic Agents Commonly Used in Veterinary Medicine, and the Associated Risks
Table 3.21: Bacterial and Protozoal Threats to Poultry
Table 3.22: Bacterial and Protozoal Threats to Pigs
Table 3.23: Elanco Veterinary Products Summary
Table 3.24: Schering-Plough Products Acquired by Pfizer Animal Health, 2008
Table 3.25: Fort Dodge Animal Health Products Acquired by Pfizer in 2009
Table 4.1: Global Sales of Feed Additives for Animal Health, 2005-2014
Table 4.2: Target Species and Brand Names for Probiotics
Table 4.3: Feed Additives: Antimicrobials and Growth Promotants
Table 4.4: Feed Additives: Anthelmintics
Table 4.5: U.S. Beef Exports, 2002-2008
Table 4.6: Retail Equivalent Value of U.S. Beef Industry, 2002-2008
Table 4.7: U.S. Beef Consumption, 2002-2008
Table 4.8: Use of Antibiotics as Growth Promotants
Table 4.9: Global Market for Livestock Performance Enhancers, 2004-2012
Table 5.1: Veterinary Diagnostics World Market, 2005-2012
Table 5.2: Veterinary Immunodiagnostic Testing World Markets, 2005-2012
Table 7.1: Labs That Perform Canine DNA Testing
Table 7.2: DNA (Mutation) Tests for Canine Inherited Diseases
Table 7.3: DNA (Marker) Tests for Canine Inherited Diseases
Table 7.4: Companies Producing Generic Pharmaceuticals for Animal Health
Table 7.5: Generics vs. Branded Animal Health Pharmaceuticals, 2010
Table 7.6: U.S. Animal Health Generic Pharmaceuticals in the Pipeline, 2010
Table 7.7: Veterinary Insurance Rates and Coverage for Dogs in the U.S., 2010
Table 7.8: Average Initial Claims for Common Medical Conditions in Pets, 2010
Table 8.1: Pfizer Animal Health Products
Table 8.2: Pfizer Products Patents
Table 8.3: Key Pfizer Animal Health Products
Table 8.4: Pfizer Livestock Products
Table 8.5: Pfizer Equine Products
Table 8.6: Pfizer Companion Animal Products
Table 9.1: European Animal Health Market Sales, 2005-2012